Dr. Al-Zoubi is an assistant professor at The Department of Surgery, University of Illinois College of Medicine in Peoria, IL, and the CEO of Stem Cells of Arabia, Amman Jordan. Dr. Al-Zoubi graduated from Southwestern University, Philippines, with a B.SC. in Medical Technology, received his M.S. degree in Clinical Laboratory Sciences from Rosalind. Franklin University/The Chicago Medical School, and was awarded a Ph.D. degree in immunology from the University of Illinois at Chicago. Dr Al-Zoubi is a prominent stem cell scientist in the Middle East, where he and his colleagues developed unique methods for utilization of autologous stem cells in treatment of chronic and incurable human diseases using the Jordanian Method. Dr. Al-Zoubi worked at Abbott Laboratories headquarters in Illinois, USA, where he was part of a team that developed the first LCR-based system for early and fast detection of Mycobacterium tuberculosis and other infectious substances. Then, he worked as a manager of The Respiratory Cell and Molecular Biology Research Laboratory at The University of Illinois at Chicago, where they worked on the development of novel gene therapy systems for treatment of asthma and smooth muscle diseases. Additionally, Dr. Al-Zoubi worked at Miltenyi Biotec, Inc., CA, as a scientist, where he worked on a novel system for magnetically purifying antigen-specific, cytokine-secreting T lymphocytes in immune therapy of cancers and infectious diseases. Dr. Al-Zoubi moved to The Middle East in 2005, where he formed research and clinical trial groups in Jordan, Egypt, Oman, Syria, and United Arab Emirates, for utilizing stem cells in the treatment of hematological diseases, immune deficiencies, spinal cord injuries, cardiac disorders, and other chronic human diseases. Dr. Al-Zoubi is a council member of the International Association of Neurorestoratology (IANR), a founding member of The International Stem Cell Academy, a member of the International Stem Cell Study Group Association (ISCSG), and the American Association for Cancer Research (AACR).